INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,398 | – | 279 | – | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 21 | +133.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 9 | -73.5% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 34 | -8.1% | 0.00% | – |
| Q4 2021 | $4,000 | -55.6% | 37 | -46.4% | 0.00% | -100.0% |
| Q3 2021 | $9,000 | 0.0% | 69 | +27.8% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | +28.6% | 54 | -40.7% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | +250.0% | 91 | +102.2% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 45 | +73.1% | 0.00% | – |
| Q3 2020 | $1,000 | – | 26 | +44.4% | 0.00% | – |
| Q2 2020 | $0 | – | 18 | -14.3% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 21 | -63.8% | 0.00% | – |
| Q4 2019 | $1,000 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |